Sarepta Therapeutics ( NASDAQ: SRPT) faces an “arduous and treacherous path” to bring its gene therapy Elevidys back to market, according to a STAT report citing a senior FDA official, suggesting the ...

Marlboro parent Philip Morris International Inc. (NYSE:PM) saw its stock dip on Tuesday following the release of its ...

Verizon Communications helped lead the way and rose 4%. The telecom giant reported a stronger profit for the latest quarter ...

Shares of healthcare staffing company AMN Healthcare Services (NYSE:AMN) jumped 6% in the afternoon session after Truist Securities reiterated its 'Buy' rating on the company. The Wall Street firm ...

Sarepta Therapeutics' recent setbacks and restructuring have pressured Arrowhead's share price. Read why I am reiterating my bullish rating on ARWR stock.

Wall Street traders gearing up for the start of the megacap earnings season sent stocks wavering near a record, with ...

Sarepta Therapeutics is pausing shipments of its gene therapy for muscular dystrophy following several patient deaths that ...

Shares of Sarepta Therapeutics SRPT are declining in the pre-market hours today after the announcement that it will ...

The company agreed to voluntarily halt shipments of its experimental medicine Elevidys for Duchenne muscular dystrophy.

Real-time index price for TSX Composite Index (TXCX), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Conditions in South Florida’s immigration detention centers during the Trump administration’s ongoing crackdown have been described as degrading and dehumanizing—violating international human-rights ...

U.S. stock indexes inched their way to more records Monday to kick off a week full of profit updates from big U.S. companies.